Monitoring Cardiac Symptoms? HeartBeam Extends Pact With Samsung For LIVMOR Solutions
Portfolio Pulse from Nabaparna Bhattacharya
HeartBeam, Inc. (NASDAQ:BEAT) has extended its strategic alliance agreement with Samsung Electronics Co Ltd (OTC:SSNGY) (OTC:SSNLF) to assess and monitor cardiac symptoms using HeartBeam's patented technology. The deal builds on the existing partnership between HeartBeam's recently-acquired LIVMOR and Samsung.
May 30, 2023 | 4:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HeartBeam extends its strategic alliance with Samsung to assess and monitor cardiac symptoms, potentially expanding its product capabilities.
The extended partnership with Samsung will allow HeartBeam to further develop and integrate its patented technology into Samsung's products, potentially expanding its market reach and product capabilities. This is likely to have a positive impact on HeartBeam's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Samsung extends its strategic alliance with HeartBeam, potentially enhancing its product offerings in the health tech sector.
The extended partnership with HeartBeam will allow Samsung to integrate HeartBeam's patented technology into its products, potentially enhancing its product offerings in the health tech sector. This is likely to have a positive impact on Samsung's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Samsung extends its strategic alliance with HeartBeam, potentially enhancing its product offerings in the health tech sector.
The extended partnership with HeartBeam will allow Samsung to integrate HeartBeam's patented technology into its products, potentially enhancing its product offerings in the health tech sector. This is likely to have a positive impact on Samsung's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100